| dc.contributor |
Epicentre, 8 Rue Saint Sabin, 75011 Paris, France. francesco.grandesso@epicentre.msf.org |
|
| dc.creator |
Grandesso, F |
|
| dc.creator |
Bachy, C |
|
| dc.creator |
Donam, I |
|
| dc.creator |
Ntambi, J |
|
| dc.creator |
Habimana, J |
|
| dc.creator |
D'Alessandro, U |
|
| dc.creator |
Maikere, J |
|
| dc.creator |
Vanlerberghe, V |
|
| dc.creator |
Kerah, C H |
|
| dc.creator |
Guthmann, J P |
|
| dc.date |
2006-05 |
|
| dc.date.accessioned |
2017-01-31T07:09:19Z |
|
| dc.date.available |
2017-01-31T07:09:19Z |
|
| dc.identifier |
Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad. 2006, 100 (5):419-26 Trans. R. Soc. Trop. Med. Hyg. |
|
| dc.identifier |
0035-9203 |
|
| dc.identifier |
16297419 |
|
| dc.identifier |
10.1016/j.trstmh.2005.07.017 |
|
| dc.identifier |
http://hdl.handle.net/10144/17279 |
|
| dc.identifier |
http://fieldresearch.msf.org/msf/handle/10144/17279 |
|
| dc.identifier |
Transactions of the Royal Society of Tropical Medicine and Hygiene |
|
| dc.identifier.uri |
http://dspace.mediu.edu.my:8181/xmlui/handle/10144/17279 |
|
| dc.description |
We report two 28-day in-vivo antimalarial efficacy studies carried out in the urban centres of Bongor and Koumra, southern Chad. We assess chloroquine (CQ), sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) to treat Plasmodium falciparum uncomplicated malaria. Methods and outcome classification complied with latest WHO guidelines. Out of the 301 and 318 children aged 6-59 months included in Bongor and Koumra, respectively, 246 (81.7%) and 257 (80.8%) were eligible for analysis. In Bongor and Koumra, the 28-day PCR-adjusted failure rates for CQ were 23.7% (95% CI 14.7-34.8%) and 32.9% (95% CI 22.1-45.1%), respectively, and those for SP were 16.3% (95% CI 9.4-25.5%) and 4.3% (95% CI 1.2-10.5%). AQ failure rates were 6.4% (95% CI 2.1-14.3%) and 2.2% (95% CI 0.3-7.6%). The current use of CQ in Bongor and Koumra is questionable, and a more efficacious treatment is needed. Considering the reduced efficacy of SP in Bongor, AQ seems to be the best option for the time being. Following WHO recommendations that prioritize the use of artemisinin-based combinations, artesunate plus amodiaquine could be a potential first-line treatment. Nevertheless, the efficacy of this combination should be evaluated and the change carefully prepared, implemented and monitored. |
|
| dc.language |
en |
|
| dc.publisher |
Elsevier |
|
| dc.relation |
http://www.sciencedirect.com/science/journal/00359203 |
|
| dc.rights |
Archived on this site with the kind permission of Elsevier Ltd. and the Royal Society of Tropical Medicine and Hygiene, http://www.rstmh.org/transactions.asp |
|
| dc.title |
Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad. |
|